HSP Insufficient Legal Proof Of PPA/Stroke Causation - Defense Attorney
This article was originally published in The Tan Sheet
Executive Summary
The Hemorrhagic Stroke Project's narrow conclusions limit the study's usefulness for establishing medical causation in lawsuits for PPA-related stroke, a defense attorney opined at a conference in Philadelphia March 12-13.
You may also be interested in...
PPA Increases Hemorrhagic Stroke Risk - Yale Study
The use of OTC cough/cold remedies or appetite suppressants containing phenylpropanolamine (PPA) increases the odds of hemorrhagic stroke by a factor of 1.49, according to a paper entitled "Phenylpropanolamine & Risk of Hemorrhagic Stroke: Final Report of the Hemorrhagic Stroke Project," released by Yale University May 10.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands